Create Alert
Watchlist

Concord Biotech

₹1,627.60
+3.20 (0.20%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
1,630.00
Prev. Close
1,624.40
Volume
14,223
Total traded value
2.31 Cr
Upper Circuit
1,949.20
Lower Circuit
1,299.60

Fundamentals

Market Cap₹16,968Cr
ROE20.50%
P/E Ratio(TTM)47.65
EPS(TTM)34.04
P/B Ratio9.36
Dividend Yield0.54%
Industry P/E35.33
Book Value173.27
Debt to Equity0.00
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Concord Biotech

Concord Biotech is a global company that uses the natural process of fermentation to create essential pharmaceutical ingredients for medicines, especially immunosuppressants and oncology drugs. Its main vision is to create biotechnology-based products and services that enrich people's lives by continuously growing its scientific expertise and capabilities. The company holds a strong market position with over 20% market share by volume in five of its key molecules.;
Parent OrganisationConcord Biotech
Managing DirectorMr. Ankur Vaid
NSE SymbolCONCORDBIO

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
44.08%
Retail And Others
37.95%
Foreign Institutions
9.11%
Mutual Funds
4.68%
Other Domestic Institutions
4.18%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cohance Lifesciences
NA
(0.00%)
102.84
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.38
Emcure Pharmaceuticals
NA
(0.00%)
33.75
Wockhardt
NA
(0.00%)
-195.00